Gennova Biopharmaceuticals

Jump to

Gennova's mRNA jab gets regulator nod, 1.2 million boosters approved by CDL Kasauli

The Department of Biotechnology (DBT) on June 20 announced that the Omicron-specific mRNA-based booster vaccine developed using the indigenous platform technology by Gennova was supported under the Mission Covid Suraksha.
mRNA booster shot in pipeline, says Gennova Biopharmaceuticals

After getting the nod from India's drug regulator, Gennova Biopharmaceuticals is now aiming for WHO approval for its mRNA vaccine
Indian maker of mRNA vaccine faces charges of trade secret theft, IP rights violations

HDT Bio filed a lawsuit in a Seattle court earlier this week, accusing Emcure of misappropriating trade secrets that it had licensed to unit Gennova and seeking $950 million in damages.
Hope to use mRNA COVID-19 vaccine developed in India someday: Dr VK Paul

The senior health official highlighted that Gennova Biopharmaceuticals has also developed a vaccine candidate using mRNA technology, which will work against the Omicron variant.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Gennova Biopharmaceuticals

Gennova's mRNA jab gets regulator nod, 1.2 million boosters approved by CDL Kasauli

mRNA booster shot in pipeline, says Gennova Biopharmaceuticals

Indian maker of mRNA vaccine faces charges of trade secret theft, IP rights violations

Hope to use mRNA COVID-19 vaccine developed in India someday: Dr VK Paul